GB2392839A8 - Use of Mycobacterium w in the treatment of tubercolosis - Google Patents
Use of Mycobacterium w in the treatment of tubercolosisInfo
- Publication number
- GB2392839A8 GB2392839A8 GB0400094A GB0400094A GB2392839A8 GB 2392839 A8 GB2392839 A8 GB 2392839A8 GB 0400094 A GB0400094 A GB 0400094A GB 0400094 A GB0400094 A GB 0400094A GB 2392839 A8 GB2392839 A8 GB 2392839A8
- Authority
- GB
- United Kingdom
- Prior art keywords
- tubercolosis
- mycobacterium
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN235MU2002 | 2002-03-08 | ||
PCT/IB2003/000802 WO2003075825A2 (en) | 2002-03-08 | 2003-03-04 | The method of treating tuberculosis |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0400094D0 GB0400094D0 (en) | 2004-02-04 |
GB2392839A GB2392839A (en) | 2004-03-17 |
GB2392839A8 true GB2392839A8 (en) | 2004-11-18 |
Family
ID=27799867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0400094A Withdrawn GB2392839A (en) | 2002-03-08 | 2003-03-04 | Use of Mycobacterium w in the treatment of tuberculosis |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR20050008452A (en) |
AU (2) | AU2003209534A1 (en) |
GB (1) | GB2392839A (en) |
WO (2) | WO2003075825A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006111853A2 (en) * | 2005-04-18 | 2006-10-26 | Aurobindo Pharma Limited | Stable solid dosage forms of acid labile drug |
US8048434B2 (en) * | 2005-04-25 | 2011-11-01 | Cadila Pharmaceuticals, Ltd. | Vaccine adjuvants |
CA2670124C (en) * | 2006-11-23 | 2015-04-21 | Cadila Pharmaceuticals Limited | Poly-tlr antagonist |
WO2010122583A2 (en) | 2009-04-24 | 2010-10-28 | Rubicon Research Private Limited | Oral pharmaceutical compositions of acid labile substances |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8404280D0 (en) * | 1984-02-17 | 1984-03-21 | Stanford J L | Biological preparations |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
GB9219425D0 (en) * | 1992-09-14 | 1992-10-28 | Univ London | Therapeutic agent and its use |
GB8918206D0 (en) * | 1989-08-09 | 1989-09-20 | Nat Inst Immunology | Tuberculosis vaccine |
US5232706A (en) * | 1990-12-31 | 1993-08-03 | Esteve Quimica, S.A. | Oral pharmaceutical preparation containing omeprazol |
SE9302395D0 (en) * | 1993-07-09 | 1993-07-09 | Ab Astra | NEW PHARMACEUTICAL FORMULATION |
WO2003063896A1 (en) * | 2002-01-29 | 2003-08-07 | Modi, Rajiv, Indravadan | Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals |
JP2006502090A (en) * | 2002-01-29 | 2006-01-19 | モディ,ラジヴ,インドラヴァーダン | Methods providing prevention for tuberculosis in HIV positive individuals |
-
2003
- 2003-03-04 KR KR10-2003-7015464A patent/KR20050008452A/en not_active Application Discontinuation
- 2003-03-04 GB GB0400094A patent/GB2392839A/en not_active Withdrawn
- 2003-03-04 WO PCT/IB2003/000802 patent/WO2003075825A2/en not_active Application Discontinuation
- 2003-03-04 AU AU2003209534A patent/AU2003209534A1/en not_active Abandoned
- 2003-03-06 AU AU2003208505A patent/AU2003208505A1/en not_active Abandoned
- 2003-03-06 WO PCT/IB2003/000827 patent/WO2003077829A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GB2392839A (en) | 2004-03-17 |
AU2003208505A1 (en) | 2003-09-29 |
AU2003208505A8 (en) | 2003-09-29 |
GB0400094D0 (en) | 2004-02-04 |
AU2003209534A8 (en) | 2003-09-22 |
WO2003075825A3 (en) | 2003-11-13 |
WO2003077829A3 (en) | 2003-12-04 |
WO2003077829A2 (en) | 2003-09-25 |
WO2003075825A2 (en) | 2003-09-18 |
KR20050008452A (en) | 2005-01-21 |
AU2003209534A1 (en) | 2003-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1543034A4 (en) | Treatment and prophylaxis with 4-1bb-binding agents | |
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
EP1476150A4 (en) | Carboxyfullerenes and methods of use thereof | |
GB0220214D0 (en) | Compounds and their use | |
GB0213869D0 (en) | The treatment of pain | |
GB0212405D0 (en) | Composition and its therapeutic use | |
GB0223570D0 (en) | Surface treatment | |
GB0207410D0 (en) | Compounds and their therapeutic use | |
EP1558238A4 (en) | Beta-hydroxyphenylaldylamines and their use for treating glaucoma | |
SG110107A1 (en) | Compound and use in treatment | |
GB2392839A8 (en) | Use of Mycobacterium w in the treatment of tubercolosis | |
IL164951A0 (en) | The treatment of pain with lfendropil | |
EP1683765A4 (en) | Water treatment unit and equipment having the unit | |
EP1569928A4 (en) | Therapeutic compounds and methods | |
GB2386839B (en) | Apparatus for use in the treatment of choanal atresia | |
GB0207409D0 (en) | Benzofuran-2H-3-one compounds and their therapeutic use | |
IL174968A0 (en) | The use of ifenprodil in the treatment of pain | |
GB0211297D0 (en) | Pain treatment | |
GB0218031D0 (en) | Compounds and their use | |
AU2003263224A8 (en) | Polishing composition and methods | |
GB0215773D0 (en) | Compunds and their therapeutic use | |
GB0325957D0 (en) | The treatment of pain | |
GB0220215D0 (en) | Compounds and their use | |
GB0223779D0 (en) | Use and process | |
GB0325598D0 (en) | Compound and use in treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
713D | Proc. under sect. 13(1) pat. act 1977 ** appl. filed | ||
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
713F | Application for mention of inventor (sect. 13(1)/1977) allowed | ||
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |